On December 11, Gelonghui reported that Sanyuan Biology (301206.SZ) announced that it recently received a notification letter from shareholder Luxin Capital, which holds over 5% of the shares, titled "Notice of Shareholding Reduction Exceeding 1% and Change of Rights Reaching 5%" and "Brief Report on Equity Changes." From November 11, 2024, to December 10, 2024, Luxin Capital has cumulatively reduced its shareholdings by 2,627,650 shares, with the total reduced shareholding ratio having reached 1.3021% of the current total share capital of the company (excluding the 525,700 shares in the company’s repurchase special securities account). At the same time, considering the previously disclosed reduction situation, from March 7, 2023, to December 10, 2024, Luxin Capital has cumulatively reduced 10,107,650 shares through centralized bidding and block trades, reducing its holdings in the company from 24,780,000 shares to 14,672,350 shares, with the shareholding ratio decreasing from 12.25% to 7.25% (if calculated based on the total share capital of 202,325,700 shares excluding the repurchased shares of 525,700 shares, the shareholding ratio decreases to 7.27%).